Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis - Summary - MDSpire

Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis

  • By

  • Yunlong Fan

  • Jun Zhu

  • Lingling Jiang

  • Jia Xu

  • Jinqun Huang

  • June 10, 2026

  • 0 min

Share

Objective:

To systematically evaluate the effect of combined pelvic and para-aortic lymphadenectomy (PPaLND) versus pelvic lymphadenectomy alone (PLND) or no lymphadenectomy on overall survival (OS) in patients with endometrial cancer, focusing on risk-stratified subgroup analyses.

Approach:
    Key Findings:
    • Fourteen studies (1 RCT, 13 retrospective) comprising 25,432 patients were included.
    • PPaLND was associated with a significant improvement in OS compared to no lymphadenectomy (HR = 0.61, 95% CI: 0.49–0.75).
    • Compared to PLND, PPaLND showed a survival benefit in the overall population (HR = 0.60, 95% CI: 0.44–0.81).
    • No statistically significant differences were observed in the intermediate-to-high-risk subgroup when comparing PPaLND to PLND (HR = 0.62, 95% CI: 0.31–1.24).
    • Sensitivity analysis revealed significant changes in results for the intermediate-to-high-risk subgroup upon exclusion of specific studies.
    Interpretation:

    Limitations:
    • The observational nature of the evidence limits the robustness of findings.
    • The wide confidence intervals in some subgroups indicate very low statistical power.
    Conclusion:

Original Source(s)

Related Content